Skip to content

Change in Inventories at other companies

Illumina logo
IlluminaILMN
$13M+230%
Revvity logo
RevvityRVTY
$12.84M+134%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
-$33K+92.7%
Agilent Technologies logo
Agilent TechnologiesA
$46M+4,500%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$590K+122%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
-$2.7M+66.5%

Other financials

Income statement

See full
Revenue$37.2M+0.1%
Gross profit$12.8M+1,037%
Operating income-$8.4M+98.1%
Net income-$8.3M+98.1%
EPS (diluted)-$0.03+97.9%

Balance sheet

See full
Cash & equivalents$57.9M-4.7%
Total debt$59.3M+12.1%
Total equity$2.4M-97.4%
Total assets$782.4M-9.1%

Cash flow

See full
Operating cash flow-$44.7M-1.4%
CapEx$3.0M+119%
Free cash flow-$47.7M-5.0%

Valuation

See full
Market cap$496.96M+30.4%
Enterprise value$498.38M+33.5%
P/S3.1×+0.6×

Profitability

See full
Gross margin37.5%+21.3pp
Operating margin-83.3%-38.2pp
Net margin-80.3%-36.1pp
FCF margin-72.6%-20.0pp

Returns & leverage

See full
Return on equity-273.6%+314pp
Debt / equity25.1×+24.5×
Current ratio5.7×-1.0×

Where this comes from

Reported directly by Pacific Biosciences of California in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacific Biosciences of California's change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacific Biosciences of California's change in inventories?
Pacific Biosciences of California (PACB) reported change in inventories of $3.21M in Q1 2026.
How has Pacific Biosciences of California's change in inventories changed year-over-year?
Pacific Biosciences of California's change in inventories increased by 26.3% year-over-year, from $2.54M to $3.21M.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.